Effect of Cyclandelate on Sudden Hearing Loss: Study of Five Cases

Authors

  • Ashish Katarkar
  • Dr. Maulik Shah
  • Noorain Alam
  • Dr. Pankaj Shah
  • Dr. Anil Jain

DOI:

https://doi.org/10.37591/rrjohp.v2i1.823

Abstract

Sudden sensorineural hearing loss is one of the most perplexing and controversial, unsolved mystery. It is an idiopathic hearing loss of sensorineural origin, greater than 30 dB in three contiguous frequencies that occurs in less than three days. Cyclandelate is a peripheral vasodilator and improves blood flow. Pre- and post-treatment (4 weeks) audiological assessment was done. The standardized protocol was Tab. Cyclandelate, Methylcobalamine and Cetrizine. Pre-treatment pure-tone audiometry showed moderate loss in two ears, severe in one ear, and profound in two ears. Post-treatment pure-tone audiometry, hearing was normal in one ear, mild loss in three ears and moderate in one ear. The average hearing improvement of 70 dB was achieved. If Cyclandelate is given alone it is effective in 80% patients as compared to long list of treatment regime. It is cost effective and key to unsolved mystery.

 

Keywords: Sudden hearing loss, cyclandelate, peripheral vasodilator

Downloads

Published

2019-03-18

Issue

Vol. 2 No. 1 (2012)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.